Spyglass Pharma Funding: $200M Raised, Series D (2025)
Spyglass Pharma is a Biotech company based in Irvine, California. It has raised $200M in total funding. Latest round: Series D.
Spyglass Pharma funding overview
Spyglass Pharma is a Biotech company based in Irvine, California. Spyglass Pharma has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in June 2025. The round record for Spyglass Pharma runs through 2025; nothing later has been disclosed.
Spyglass Pharma at a glance
Total raised
$200M
Latest round
Series D
Latest round date
June 2025
Industry
Biotech
Headquarters
Irvine, California
Frequently asked about Spyglass Pharma funding
How much has Spyglass Pharma raised?
Spyglass Pharma has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Spyglass Pharma?
No investors are named on the public record for Spyglass Pharma yet.
What was the latest Spyglass Pharma funding round?
The most recent disclosed round is a Series D, announced in June 2025.
Where is Spyglass Pharma based?
Spyglass Pharma is based in Irvine, California.
What sector does Spyglass Pharma operate in?
Spyglass Pharma is tracked under Biotech from Irvine, California, with $200M in disclosed funding.
When did Spyglass Pharma last raise?
The last disclosed Spyglass Pharma round closed in June 2025 at Series D.
Round data for Spyglass Pharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Irvine and backer lists below.
